Patent: 8,333,963
✉ Email this page to a colleague
Summary for Patent: 8,333,963
| Title: | Method of inhibiting osteoclast activity |
| Abstract: | Methods for inhibiting osteoclastogenesis by administering a soluble RANK polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer. |
| Inventor(s): | Anderson; Dirk M (Port Townsend, WA), Galibert; Laurent J (Prevessin Moens, FR) |
| Assignee: | Immunex Corporation (Thousand Oaks, CA) |
| Application Number: | 12/850,368 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,333,963
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 06/01/2010 | ⤷ Try a Trial | 2016-12-23 |
| Amgen, Inc. | XGEVA | denosumab | Injection | 125320 | 11/18/2010 | ⤷ Try a Trial | 2016-12-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,333,963
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | 401404 | ⤷ Try a Trial |
| Austria | 412746 | ⤷ Try a Trial |
| Austria | 497001 | ⤷ Try a Trial |
| Austria | 517916 | ⤷ Try a Trial |
| Australia | 3988899 | ⤷ Try a Trial |
| Australia | 5618098 | ⤷ Try a Trial |
| Australia | 5718498 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
